FDA Warns to Exercise Caution When Using Pen Needles to Inject Medicines

The FDA has received reports of patients using standard pen needles to inject insulin without removing the inner needle cover. In these cases, the inner cover stopped the needle from entering the skin and the patients did not get the insulin. Some patients developed high blood sugar (hyperglycemia) because the inner needle cover stopped them from getting insulin.  One patient was hospitalized and died because of having blood sugar that was too high for too long.    To help people use pen needles safely, the FDA provides recommendations for patients, caregivers, healthcare providers and Health Care educators.

The safety communication references an ISMP NAN Alert related to this topic.


More News

Healthcare Leaders Urged to Avoid Severity Bias, Establish Just Culture In the wake of recent criminal charges being filed against a registered nurse in Tennessee who was involved in a fatal medication error, the Institute for Safe Medication Practices (ISMP) is emphasizing that the focus should be